Cold & Cough Remedies - Sri Lanka

  • Sri Lanka
  • In Sri Lanka, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$51.94m.
  • It is projected that the market will experience an annual growth rate of 5.21% (CAGR 2024-2029).
  • When compared to other countries around Worldwide, the in the United States generates the highest revenue in the Cold & Cough Remedies market market, with a value of US$11,190.00m in 2024.
  • Taking into account the population figures, in 2024, each person in Sri Lanka contributes US$2.37 in revenue towards the Cold & Cough Remedies market market.
  • Sales of Cold & Cough Remedies in the Sri Lankan OTC Pharmaceuticals market have seen a significant increase due to the country's high prevalence of respiratory illnesses.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Sri Lanka is showing steady growth and development.

Customer preferences:
In Sri Lanka, customers are increasingly seeking out Cold & Cough Remedies products to alleviate their symptoms and improve their overall health. With the rise of health consciousness and awareness, consumers are becoming more proactive in managing their health and are turning to over-the-counter remedies to treat their cold and cough symptoms. Additionally, the convenience and accessibility of these products make them a popular choice among consumers.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Sri Lanka is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives. This trend is driven by the belief that natural remedies are safer and have fewer side effects compared to traditional pharmaceutical products. As a result, companies in the market are introducing more natural and herbal options to cater to this demand.Another trend in the market is the increasing availability of Cold & Cough Remedies products in various formats. Traditionally, these products were available in the form of tablets or syrups. However, there has been a shift towards more convenient formats such as lozenges, nasal sprays, and inhalers. These formats offer ease of use and portability, allowing consumers to manage their symptoms on-the-go.

Local special circumstances:
Sri Lanka has a tropical climate, which makes it prone to seasonal changes and fluctuations in temperature. These changes can often lead to an increase in cold and cough cases, creating a higher demand for Cold & Cough Remedies products. Additionally, the country's high population density and urbanization contribute to the spread of respiratory infections, further driving the demand for these products.

Underlying macroeconomic factors:
The growing middle class in Sri Lanka has led to an increase in disposable income, allowing consumers to spend more on healthcare products. This has positively impacted the Cold & Cough Remedies market, as consumers are willing to invest in products that can help them manage their symptoms and improve their quality of life. Furthermore, the expanding retail sector and the availability of these products in pharmacies, supermarkets, and online platforms have made them easily accessible to a wider consumer base.In conclusion, the Cold & Cough Remedies market in Sri Lanka is witnessing growth due to the increasing customer preference for these products, the introduction of natural and herbal remedies, the availability of products in various formats, the local climate and population density, and the underlying macroeconomic factors such as the growing middle class and expanding retail sector.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)